Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TFV/LNG IVR Safety, PK, and PD Study
NCT03279120Phase 1Completed
- Sponsor
- CONRAD
- Start
- Sep 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of tenofovir and avatrombopag in human immunodeficiency virus infection (HIV) and pregnancy, sponsored by CONRAD. Started Sep 2017; status: completed.
02
Drugs
tenofoviravatrombopag
03
Conditions
human immunodeficiency virus infection (HIV)pregnancy
Beyond the preview
Go deeper on NCT03279120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03279120.